about
sameAs
Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteersProphylactic Measures During Induction for Acute Myeloid Leukemia.Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.Antibiotic precautions in athletesCommunity-acquired pneumonia in elderly patients.QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.Novel antibacterial agents for the treatment of serious Gram-positive infections.Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study.Effects of three fluoroquinolones on QT analysis after standard treatment courses.Microbiome at the Frontier of Personalized Medicine.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis
P2860
Q24607103-2D0541B1-FD71-4889-8CB4-E5A6B603E014Q30235496-76DE9FE8-2D3D-4EA4-9B17-2A2AC964443BQ33151312-4B84812F-A09B-4AB4-B874-479CB3A49072Q33739099-82E79275-85A3-4A51-BE2B-AD2FA4EC8F27Q33786181-3DA7FAF7-37C7-49A7-B8B3-3ED9128EC746Q34048462-5901719C-60E2-48C1-A322-44C477CD3C77Q34634216-C3687F2E-CBA9-4710-A1C7-807496EB90FBQ35073345-1ED3B9BD-A9C9-4912-94C1-0E828845B8D5Q36166676-A4F1A796-9C50-4D79-9EE8-18627253C567Q38819976-6B296EDF-A2E2-437D-8D5E-9A00D8D7628CQ39147393-DDBCD7A8-0482-4431-B294-F854DC6A1AB4Q40381055-678DCCC4-EA9E-419F-AA16-3A968786BCA6Q42680174-2FB1A2D3-BE21-4437-BDD9-118D7A1CA1D3Q46248509-03677E64-7669-4943-87A0-E58545971498Q47332682-0A096CC7-7575-4BD4-8CC0-EB3102F6C2ADQ57775011-67382548-08D3-441E-B1A2-9296E5A867EB
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cardiotoxicity of fluoroquinolones
@ast
Cardiotoxicity of fluoroquinolones
@en
Cardiotoxicity of fluoroquinolones
@nl
type
label
Cardiotoxicity of fluoroquinolones
@ast
Cardiotoxicity of fluoroquinolones
@en
Cardiotoxicity of fluoroquinolones
@nl
prefLabel
Cardiotoxicity of fluoroquinolones
@ast
Cardiotoxicity of fluoroquinolones
@en
Cardiotoxicity of fluoroquinolones
@nl
P2860
P356
P1476
Cardiotoxicity of fluoroquinolones
@en
P2093
Ethan Rubinstein
P2860
P356
10.1093/JAC/49.4.593
P407
P577
2002-04-01T00:00:00Z